Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients

Lupus

Volumn 8, Issue 8, 1999, Pages 638-644

  FitzGerald, John D ^a   Grossman, J M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disease activity; Flare; Lupus; Reliability; Retrospective; Validity

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; COHORT STUDIES; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; OBSERVER VARIATION; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 0032707520     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399680411443     Document Type: Article

References (11)

1. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.
2. Hawker G, Gabriel S, Bombardier C et al. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus (published erratum appears in J Rheumatol 1993 Jun; 20(6): 1091). J Rheumatol 1993; 20: 657-660.
3. Wluka AE, Liang MH, Partridge AJ et al. Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation. Arthritis Rheum 1997; 40: 57-61.
4. Arce-Salinas A, Cardiel MH, Guzman J, Alcocer-Varela J. Validity of retrospective disease activity assessment in systemic lupus erythematosus. J Rheumatol 1996; 23: 846-849.
5. Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 1992: 19: 53-59.
6. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991; 34: 937-944.
7. Petri M, Buyon JP, Skovorn ML. Reliability of SELENA SLEDAl and flare as clinical trial outcome measures. Arthritis Rheum 1998; 41: S218 (Abstract).
8. Kalunian K. Personal communication, January 1999. Components of the SELENA visit tool.
9. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
10. Fleiss J. The Design and Analysis of Clinical Experiments. In: Wiley (ed) The Design and Analysis of clinical Experiments. 1986, Wiley: New York.
11. Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988; 31: 817-825.